Modestus Obochi
Corporate Officer/Principal bei SERNOVA CORP.
Vermögen: - $ am 31.03.2024
Profil
Modestus Obochi is currently the Director at Temprian Therapeutics, Inc. and the Chief Business Officer at Sernova Corp.
Previously, he held the positions of President, Chief Executive Officer & Director at Coeptis Therapeutics, Inc., Head-Strategy & Business Development Executive at Pelican Inc, and Executive VP-Strategy & Business Development at Phlow Corp.
Dr. Obochi obtained a doctorate degree from the University of British Columbia and an MBA from Beedie School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SERNOVA CORP.
-.--% | 08.09.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Modestus Obochi
| Unternehmen | Position | Beginn |
|---|---|---|
| SERNOVA CORP. | Corporate Officer/Principal | 08.09.2023 |
Temprian Therapeutics, Inc.
 Temprian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Temprian Therapeutics, Inc. develops therapies for autoimmune disease. The company is headquartered in Chicago, IL. | Director/Board Member | 01.08.2022 |
Ehemalige bekannte Positionen von Modestus Obochi
| Unternehmen | Position | Ende |
|---|---|---|
Phlow Corp.
 Phlow Corp. Pharmaceuticals: MajorHealth Technology Phlow Corp. engages in the pharmaceutical manufacturing. The firm manufactures precursor chemical ingredients, active pharmaceutical ingredients (API), and finished pharmaceutical products. The company was founded by Eric Edwards and Frank Gupton and is headquartered in Richmond, VA. | Corporate Officer/Principal | 01.09.2023 |
| VININGS HOLDINGS INC. | Chief Executive Officer | 01.03.2020 |
| PFENEX INC. | Corporate Officer/Principal | 01.02.2019 |
Ausbildung von Modestus Obochi
| University of British Columbia | Doctorate Degree |
| Beedie School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SERNOVA CORP. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Coeptis Therapeutics, Inc.
 Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Coeptis Therapeutics, Inc. is a pharmaceutical company focused on the development of therapeutics and technologies to disrupt conventional treatment paradigms. Its product portfolio includes CD38-GEAR-NK and a CD38-Diagnostic, which is focused on CD38-related cancers. The company was founded on February 15, 1996 and is headquartered in Wexford, PA. | Health Technology |
Pelican Inc
 Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
Temprian Therapeutics, Inc.
Temprian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Temprian Therapeutics, Inc. develops therapies for autoimmune disease. The company is headquartered in Chicago, IL. | Health Technology |
Phlow Corp.
Phlow Corp. Pharmaceuticals: MajorHealth Technology Phlow Corp. engages in the pharmaceutical manufacturing. The firm manufactures precursor chemical ingredients, active pharmaceutical ingredients (API), and finished pharmaceutical products. The company was founded by Eric Edwards and Frank Gupton and is headquartered in Richmond, VA. | Health Technology |
